This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: John R La Montagne: Innovator in Vaccine Development
Introduction
John R La Montagne is a prominent inventor based in Alexandria, VA (US). He has made significant contributions to the field of vaccine development, particularly in addressing human rotaviral diseases. His work is especially focused on creating solutions for developing countries, where such diseases pose a substantial health risk.
Latest Patents
La Montagne holds a patent for a hexavalent bovine rotavirus reassortant composition designed for use in developing countries. This innovative vaccine composition aims to protect against human rotaviral disease by combining human-bovine reassortant rotavirus strains. The formulation includes the four clinically most important VP7 serotypes of human rotavirus, along with other VP7 serotypes typically found in specific regions. This multivalent approach ensures a high degree of infectivity and immunogenicity. Additionally, the patent outlines methods and an administration protocol that produce an immunogenic response while minimizing the risk of intussusception.
Career Highlights
La Montagne is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to focus on critical health issues and contribute to public health advancements through innovative vaccine research.
Collaborations
Throughout his career, La Montagne has collaborated with notable colleagues, including Albert Z Kapikian and Lone Simonsen. These partnerships have further enhanced the impact of his research and innovations in the field of vaccine development.
Conclusion
John R La Montagne's contributions to vaccine development, particularly in creating solutions for developing countries, highlight his commitment to public health. His innovative approaches and collaborations with esteemed colleagues continue to make a significant impact in the fight against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile